|
|
||||||||
Department of Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the effects of various amino acids on responses to ATP-sensitive potassium (KATP) channel openers in anesthetized cats equipped with cranial windows. The application of pinacidil by superfusion caused transient vasodilation, whereas there was sustained vasodilation from the application of stationary solution of pinacidil. In the presence of L-arginine or L-lysine, pinacidil by superfusion led to sustained vasodilation, suggesting that the rapid flow of fluid displaced these amino acids from binding on the channel and that such binding was essential for opening the channel. NG-nitro-L-arginine blocked responses to pinacidil, and this blockade was reversed by L-lysine or L-arginine but not by D-arginine, D-lysine, methyl-L-arginine, glycine, L-histidine, dimethylarginine, dimethyl-L-arginine, or hydroxylysine. The blockade of responses to pinacidil induced by glyburide was also reversed completely by L-arginine or L-lysine but not by D-arginine, suggesting that these amino acids act on the sulfonylurea receptor. Hydroxylysine but not methyl-L-lysine, dimethylarginine, or dimethyl-L-arginine blocked responses to pinacidil. The findings show that KATP channels in cerebral arterioles need L-lysine or L-arginine to open in response to agonists.
vasodilation; cerebral circulation; vascular smooth muscle; membrane ion channels; glyburide
| |
INTRODUCTION |
|---|
|
|
|---|
IN AN EARLIER STUDY (7), we found that NG-nitro-L-arginine (L-NNA) and NG-monomethyl-L-arginine (L-NMMA) inhibited the cerebral arteriolar dilation from cromakalim, minoxidil, and pinacidil, three agents that dilate vessels by opening ATP-sensitive potassium (KATP) channels. This effect of the arginine analogs was not dependent on blockade of nitric oxide synthase and was unrelated to nitric oxide, since the action of nitric oxide donors was not modified by blockade of KATP channels with glyburide (7). The inhibitory effect of arginine analogs was reversed by L-arginine, suggesting that the effect of the arginine analogs on potassium channels might involve competition with L-arginine. We suggested that KATP channels in cerebral arterioles require L-arginine for their function (7). In addition, we surmised that the requirement for L-arginine may be because of the presence of an arginine site on the channel that must be occupied for the ion channel to open (7). There is precedent for such an arrangement. A membrane calcium channel in neurons, the N-methyl-D-aspartate (NMDA) receptor, has a glycine site, which when occupied potentiates the action of agonists in opening this ion channel (6).
In the present study, we investigated further the role of arginine and other amino acids in the function of KATP channels in cerebral arterioles of anesthetized cats.
| |
METHODS |
|---|
|
|
|---|
Experiments were carried out in cats anesthetized with pentobarbital sodium (30 mg/kg iv). Additional doses of anesthetic were given as required to maintain surgical anesthesia, based on testing of corneal reflexes and on responses to tail pinch. The animals were subjected to tracheostomy and ventilated with a positive-pressure respirator. The end-expiratory CO2 of the animals was continuously monitored with a Hewlett-Packard CO2 analyzer and was maintained at a constant level of ~30 mmHg. Arterial blood pressure was measured with a pressure transducer connected to a cannula introduced into the aorta via the femoral artery. Arterial blood samples were collected for determination of arterial blood oxygen, CO2 partial pressures, and pH at appropriate intervals during the experiment. Blood gas tensions and pH were measured with Corning electrodes. The rectal temperature of the animal was monitored continuously and was kept constant with the aid of a heating blanket.
The cerebral microcirculation of the parietal cortex was visualized through an acutely implanted cranial window as described in detail previously (8). The space under the cranial window was filled with artificial cerebrospinal fluid (CSF) identical in composition to that of cats. One port of the window was connected to a pressure transducer for continuous monitoring of intracranial pressure. The intracranial pressure was maintained at 5 mmHg by connecting another outlet of the window to a coiled plastic tube whose free end was placed at the appropriate height to give the desired pressure. Two ports of the cranial window were used as inlet and outlet, allowing topical application of various solutions either by filling the space under the window with stationary solution or by superfusion. Pial arteriolar diameter was measured with a Vickers image-splitting device attached to a Wild microscope. In each animal, several arterioles were observed covering a wide range of vessel caliber. The responses of small and large arterioles (smaller and larger than 100 µm in diameter, respectively) were analyzed separately to identify any size-dependent differences in responses.
Pinacidil, minoxidil, L-NNA,
L-arginine,
D-arginine,
L-lysine,
D-lysine, glycine,
L-histidine,
methyl-L-lysine,
-hydroxylysine, dimethyl-L-arginine,
dimethylarginine, and glyburide were obtained from Sigma. Hydroxylysine
contained equal parts of D- and
L-lysine. Pinacidil, minoxidil,
and glyburide were first dissolved in ethyl alcohol to prepare a stock
solution. The diluent had no significant effect on baseline vessel
diameters. All other solutions were prepared directly in artificial CSF
immediately before use and were equilibrated at 37°C in a water
bath immediately before application.
The following series of experiments were done. 1) We tested whether L-arginine had a significant effect on the response to the known KATP channel opener pinacidil. Pinacidil was applied by filling the space under the window with the appropriate stationary solution for several minutes. Vessel diameters were measured between 2 and 4 min after the initiation of the application. This was sufficient for the vessels to reach a new steady state. The effect of pinacidil was evaluated in the presence of L-arginine in various concentrations from 0 to 500 µM.
2) The effects of various doses of L-arginine on the action of pinacidil or minoxidil were evaluated following pretreatment with L-NNA (250 µM) to block KATP channels. Responses to pinacidil or minoxidil in stationary solution were obtained before and after a 30-min topical application of 250 µM L-NNA. The responses to pinacidil or minoxidil were evaluated again in the presence of 5 µM D-arginine and 5 and 1,000 µM L-arginine. Similar experiments were conducted to evaluate whether other amino acids might have the same action as L-arginine. We tested the effects of D-lysine, L-lysine, glycine, L-histidine, methyl-L-lysine, dimethyl-L-arginine, dimethylarginine, and hydroxylysine on responses to pinacidil in several series of experiments.
3) In another series of experiments, we tested whether binding of L-arginine on the channel is required for opening KATP channels by known agonists. We used an experimental design similar to what has been used to identify the glycine site in NMDA receptors (6). To this end, we first tested the effect of pinacidil (1 µM) by filling the window with stationary solution containing this agent. We then applied the same concentration of pinacidil by continuous superfusion at two different rates, 1 and 3 ml/min, in the absence and presence of L-arginine. Because the volume of the space under the cranial window is ~0.25 ml, these superfusion rates gave a turnover rate of 4-12 times/min. The rationale in using this procedure was that the continuous flow of fluid might wash arginine from binding on the channel, thereby allowing us to evaluate whether arginine bound to the channel is needed for the opening of the channel. In similar experiments, we used L-lysine and D-lysine instead of arginine.
In additional experiments, we alternated topical application of pinacidil (1 µM) by superfusion at 1 ml/min and in stationary solution to see how fast restoration of dilation occurred following application of the drug in flowing solution.
4) We investigated whether hydroxylysine, methyl-L-lysine, dimethyl-L-arginine, and dimethylarginine affected responses to pinacidil. To this end, responses to stationary pinacidil were tested before and after a 30-min topical application of each of these agents.
5) In another series of experiments, we tested whether L-arginine or L-lysine was capable of reversing the blockade of KATP channels induced by glyburide. To achieve this goal, we tested responses to stationary pinacidil before and after glyburide (1 µM) in the absence as well as in the presence of 1 and 5 µM L-arginine and 5 µM D-arginine. Glyburide was applied for 30 min. In preliminary experiments in two cats, every 15 min we tested responses to stationary pinacidil (1 µM) for 90 min after application of glyburide to ascertain the duration of the blockade. In all vessels tested, responses to pinacidil did not exceed 3% of the control response before glyburide application.
In two additional groups of cats, we tested responses to stationary pinacidil (0.5 and 1 µM) before and after glyburide in the presence of 0, 0.1, 0.25, 0.5, 0.75, and 1 µM L-arginine or L-lysine to determine the dose response of the effectiveness of these amino acids to block the inhibitory action of glyburide on KATP channels.
Statistical evaluation of the results was done with analysis of variance followed by t-tests modified for multiple comparisons.
| |
RESULTS |
|---|
|
|
|---|
Figure 1 shows that the responses to pinacidil were not modified in the presence of 5, 50, and 500 µM L-arginine.
|
Figures 2 and 3
show that the responses to pinacidil or minoxidil were blocked after
application of L-NNA and that
this blockade was eliminated in the presence of 5 µM
L-arginine but not in the presence of D-arginine. An
increase in the concentration of
L-arginine to 1 mM had no
additional effect than that seen with the lower concentration. Figure
4 shows that
L-lysine had effects similar to
those of L-arginine but that
D-lysine had no significant
effect. Table 1 summarizes results of
experiments in which several other amino acids were tested for their
ability to reverse the blockade induced by
L-NNA on responses to pinacidil.
It is seen that glycine, L-histidine,
methyl-L-lysine,
-hydroxylysine,
dimethyl-L-arginine, and
dimethylarginine were incapable of reversing the blockade induced by
L-NNA.
|
|
|
|
Figure 5 shows that stationary pinacidil had a sustained vasodilator effect on cerebral arterioles for the 10-min period of observation. When, however, the same concentration of pinacidil was applied by continuous superfusion, the vasodilation was considerably less pronounced, progressively declined, and was completely eliminated within a few minutes. Pinacidil in the presence of 5 µM L-arginine applied by continuous superfusion had a sustained vasodilator effect for the full 10-min period of application, whereas pinacidil with D-arginine applied by superfusion had a transient effect. In 16 vessels in 3 cats, switching from CSF without additives to stationary pinacidil (1 µM) caused dilation that reached its maximum in 1.7 ± 0.12 min. In the same vessels, switching to stationary pinacidil (1 µM) from a 10-min superfusion at 1 ml/min with 1 µM pinacidil caused dilation that reached its maximum in 3.2 ± 0.47 min (P < 0.01). Figure 6 shows that continuous superfusion with a solution containing pinacidil and L-lysine caused sustained arteriolar dilation identical to that caused by stationary pinacidil, whereas pinacidil plus D-lysine by superfusion had virtually no effect.
|
|
Figure 7 shows the effect of L-arginine in various concentrations on the action of pinacidil applied by superfusion at 1 ml/min. No dilation was seen in response to pinacidil in the presence of 0 and 0.25 µM L-arginine. Significant dilation was first seen at 0.5 µM, and at 1 µM L-arginine, the dilation was not different from that caused by stationary pinacidil.
|
Figure 8 shows that
-hydroxylysine
blocked completely responses to pinacidil.
Methyl-L-lysine,
dimethyl-L-arginine, and
dimethylarginine did not affect responses to pinacidil in varying doses
up to 1 mM (Table 2).
|
|
Figure 9 shows that the vasodilator response to pinacidil was blocked completely by pretreatment with glyburide and that in the presence of 1 µM L-arginine the blockade induced by glyburide was eliminated, thereby restoring responses to pinacidil to the control levels. L-Arginine (5 µM) had the same effect as the lower concentration, whereas D-arginine (5 µM) was ineffective.
|
Figures 10 and 11 show that ascending concentrations of L-arginine or L-lysine inhibited the glyburide-induced blockade of dilations by pinacidil. The effect of the amino acids was detectable at 0.5 µM, and inhibition was complete at 1 µM.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The findings reported above are consistent with the view that KATP channels in cerebral arterioles of cats have an amino acid site that must be occupied by either L-arginine or L-lysine for agonists, such as pinacidil, to open these channels. The amino acid site in these channels is evidently saturated at relatively low concentrations of L-arginine or L-lysine and is fully occupied under normal physiological conditions. This accounts for the absence of a potentiating effect of L-arginine, even in high concentrations, on the response to pinacidil. The blockade of KATP channels by arginine analogs and by hydroxylysine is attributable to the displacement of L-arginine or L-lysine from binding on the channel.
The superfusion experiments reported above show that the amino acid bound on the channel can be displaced by a flow of liquid but that upon cessation of the flow the amino acid is replenished within a few minutes from endogenous sources, thereby restoring responsiveness to potassium channel openers.
Understanding of the structure of KATP channels has improved considerably as a result of successful attempts at cloning these channels (1-5). As a result of these studies, it now appears that they consist of two components: an inward rectifying potassium channel and a sulfonylurea receptor. Coexpression of these two components reconstituted a potassium channel with all the properties expected of a KATP channel, including ATP sensitivity, responsiveness to potassium channel openers like diazoxide, and blockade by sulfonylureas (5).
Our finding that the blockade by glyburide was reversed by a low dose of L-arginine or L-lysine suggests strongly that these basic amino acids bind on the channel at a site situated on the sulfonylurea receptor. The findings are consistent with competition between these basic amino acids and glyburide for binding on this receptor. It is likely that the normally prevailing concentrations of these amino acids are sufficiently low for glyburide to exert its inhibitory effect. When the concentration of L-lysine or L-arginine exceeds 1 µM, the inhibitory effect of glyburide is eliminated completely.
The sulfonylurea receptor from pancreas from rat and hamster has recently been cloned (1). It consist of 1,582 amino acids, has 2 ATP binding sites, and belongs to the ATP-binding cassette family of proteins. It appears to function by modulating the activity of the potassium pore protein (2). Sulfonylurea receptor-like proteins have recently been identified in extrapancreatic tissues (3).
On the basis of the ability of various amino acids to block responses to pinacidil or their ability to reverse blockade of responses to pinacidil induced by L-NNA, we conclude that binding on the channel is through the free extra amino group of the basic amino acids, such as occurs in L-lysine and L-arginine. Clearly, there is also stereospecificity, since the D-isomers of these amino acids are ineffective. Methyl-L-lysine in which the amino group has a methyl substitution as well as dimethyl-L-arginine in which both guanidino amino groups are substituted are ineffective. The only exception is that dimethylarginine, which has a free extra amino group, was ineffective. This may be due to the fact that the presence of the two methyl groups on the companion guanidino amino group probably renders that portion of the molecule too bulky and prevents binding on the channel. It is also clear from the results that amino acids that have a substitution close to the amino group through which binding on the channel occurs block the channel. This is the case with L-NMMA, L-NNA, as well as hydroxylysine.
It is interesting to inquire whether or not our findings in the cerebral arterioles of cats apply to larger cerebral vessels, to vessels in other vascular beds, or to KATP channels in nonvascular tissues. McCarron et al. (10) found that isolated rat posterior cerebral arteries did not dilate in response to pinacidil or cromakalim applied by superfusion, a finding consistent with our results. However, mesenteric arteries in the same experiments dilated in response to cromakalim and pinacidil (10). Similarly, isolated porcine small coronary arteries dilated in response to KATP channel openers applied by superfusion (9). These findings suggest that the requirement for L-arginine or L-lysine for the opening of KATP channels in cerebral vessels may not be shared by such channels in other vascular beds. Such differences are not surprising. In a recent review, Quale et al. (11) pointed out a number of differences in KATP channels in different vascular beds as well as differences in the properties of these channels in vascular vs. nonvascular tissues. It should be noted, however, that final decision on these issues should be based on comparisons of the effect of KATP channel openers in stationary and flowing solution with and without L-arginine or L-lysine.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institute of Neurological Disorders and Stroke Grant NS-19316.
| |
FOOTNOTES |
|---|
Address for reprint requests: H. A. Kontos, Virginia Commonwealth University, Medical College of Virginia Campus, PO Box 980549, Richmond, VA 23298-0549.
Received 8 May 1997; accepted in final form 1 December 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aguilar-Bryan, L.,
C. G. Nichols,
S. W. Wechsler,
J. P. Clement IV,
A. E. Boyd III,
G. González,
H. Herrera-Sosa,
K. Nguy,
J. Bryan,
and
D. Nelson.
Cloning of the
cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
Science
268:
423-426,
1995
2.
Ammala, C.,
A. Moorhouse,
F. Gribble,
R. Ashfield,
P. Proks,
P. A. Smith,
H. Sakura,
B. Coles,
S. J. Ashcroft,
and
F. M. Ashcroft.
Promiscuous coupling between the sulfonylurea receptor and inwardly rectifying potassium channels.
Nature
379:
545-548,
1996[Medline].
3.
Chutkow, W. A.,
M. C. Simon,
M. M. Le Beau,
and
C. F. Burant.
Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels.
Diabetes
45:
1439-1445,
1996[Abstract].
4.
Inagaki, N.,
T. Gonoi,
J. P. Clement,
N. Namba,
J. Inazawa,
G. Gonzalez,
L. Aguilar-Bryan,
S. Seino,
and
J. Bryan.
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
Science
270:
1166-1170,
1995
5.
Inagaki, N.,
Y. Tsuura,
N. Namba,
K. Masuda,
T. Gonoi,
M. Horie,
M. Mizuta,
and
S. Seino.
Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart.
J. Biol. Chem.
270:
4691-5694,
1995.
6.
Johnson, J. W.,
and
P. Ascher.
Glycine potentiates the NMDA response in cultured mouse brain neurons.
Nature
325:
529-531,
1987[Medline].
7.
Kontos, H. A.,
and
E. P. Wei.
Arginine analogs inhibit responses mediated by ATP-sensitive potassium channels.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H1498-H1506,
1996
8.
Levasseur, J. E.,
E. P. Wei,
A. J. Raper,
H. A. Kontos,
and
J. L. Patterson, Jr.
Detailed description of a cranial window technique for acute and chronic experiments.
Stroke
6:
308-317,
1975
9.
Liu, Q.,
and
N. A. Flavahan.
Hypoxic dilation of porcine small coronary arteries: role of endothelium and KATP channels.
Br. J. Pharmacol.
120:
728-734,
1997[Medline].
10.
McCarron, J. G.,
J. M. Quayle,
W. Halpern,
and
M. T. Nelson.
Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries.
Am. J. Physiol.
261 (Heart Circ. Physiol. 30):
H287-H291,
1991
11.
Quayle, J. M.,
M. T. Nelson,
and
N. B. Standen.
ATP-sensitive and inwardly rectifying potassium channels in smooth muscle.
Physiol. Rev.
77:
1165-1232,
1997
This article has been cited by other articles:
![]() |
W. I. Rosenblum, T. Horiuchi, H. H. Dietrich, K. Hongo, T. Goto, and R. G. Dacey Jr Re: Role of Endothelial Nitric Oxide and Smooth Muscle Potassium Channels in Cerebral Arteriolar Dilation in Response to Acidosis * Response Stroke, July 1, 2002; 33(7): 1742 - 1743. [Full Text] [PDF] |
||||
![]() |
W. Long, L. Zhang, and L. D. Longo Fetal and adult cerebral artery KATP and KCa channel responses to long-term hypoxia J Appl Physiol, April 1, 2002; 92(4): 1692 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, Y. Watanabe, S. W. Brusilow, R. J. Traystman, and R. C. Koehler Interaction of glutamine and arginine on cerebrovascular reactivity to hypercapnia Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1577 - H1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. S. Frame Conducted signals within arteriolar networks initiated by bioactive amino acids Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1012 - H1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marrelli, A. Khorovets, T. D. Johnson, W. F. Childres, and R. M. Bryan Jr. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H33 - H41. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |